eli lilly tirzepatide trial Lilly's Zepbound® (tirzepatide) superior to Wegovy® (semaglutide) in head-to-head showing an average weight loss of 20.2% vs. 13.7% The numbers from Lilly's Phase

High-Fat Diets, Bile, & GLP-1 We already know that dietary fat digests slowly, and essentially, when food stays in your system longer, your hunger stays satisfied longer

Exenatide Exenatide (Byetta), an incretin mimetic, is FDA approved for use as adjunctive therapy in patients whose T2DM is inadequately controlled with metformin, an SU, a TZD, or with combination of metformin plus an SU or TZD

Why GLP-1 May Cause Headaches There are several potential reasons for headaches on GLP-1

Key Takeaway: Common Push Health complaints: provider response variance and refund disputes What Do Reviews Say About Effectiveness